Sponsor or institution
Clinical trials and research at Shanghai Auzone Biological Technology Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shanghai Auzone Biological Technology Co., Ltd. that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
TTYP01 tablets for people with early symptomatic Alzheimer's disease
This study will test whether two doses of TTYP01 tablets (60 mg and 90 mg) help people aged 60–85 with early symptomatic Alzheimer's disease (MCI due to AD or mild AD dementia) compared with placebo.
-
Evaluating TTYP01 Tablets for Autism in Children and Adolescents
This study is testing if TTYP01 tablets can be a safe and effective treatment for children and teens with Autism Spectrum Disorder.
Quick answers
How many clinical trials run by Shanghai Auzone Biological Technology Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.